Optimal use of the first licensed dengue vaccine
Optimal use of the first licensed dengue vaccine: balancing benefit against potential risks
Neil Ferguson is Director of the MRC Centre for Outbreak Analysis and Modelling and the NIHR Health Protection Research Unit for Modelling Methodology. He uses mathematical and statistical models to investigate the processes shaping infectious disease pathogenesis, evolution and transmission. One focus is on the use of models as contingency planning tools for emerging human infections (such as Zika, Ebola, MERS and pandemic influenza), bioterrorist threats and livestock outbreaks. He also leads a research programme on the dynamics and control of vector-borne diseases (Zika, dengue, yellow fever and malaria). He was educated at Oxford University where he also undertook postdoctoral research, then held a readership at the University of Nottingham before moving to Imperial College. Neil is a Senior Investigator of the National Institute of Health Research, a Fellow of the UK Academy of Medical Sciences and received an OBE for his work in 2001. He advises the UK and US governments, WHO and the EU on infectious disease epidemiology, modelling and control.
Admission